Arcutis Biotherapeutics, Inc. ARQT Total costs & expenses
Total costs & expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s total costs & expenses?
- Arcutis Biotherapeutics, Inc. (ARQT) reported total costs & expenses of $114.49M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s total costs & expenses changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s total costs & expenses increased by 26.7% year-over-year, from $90.38M to $114.49M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s total costs & expenses?
- Over 4 years (2021 to 2025), Arcutis Biotherapeutics, Inc.'s total costs & expenses has grown at a 17.1% compound annual growth rate (CAGR), from $206.53M to $388.3M.
- What does total costs & expenses mean?
- This metric aggregates all operating and non-operating costs incurred by the company during a reporting period, including cost of goods sold, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the company's total resource consumption to support its business model. Monitoring this figure is essential for assessing operational efficiency and the sustainability of the company's burn rate.